Companies / Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

SLNOCIK 1484565REDWOOD CITY, CA

Financials · FY2016

Revenue$1.45M
Net income$20.89M
Total debt$49.87M
Cash$133.03M
Diluted EPS$0.39
Shares outstanding52.1M

Ownership

52.1M shares outstanding · as of Apr 30, 2026
1.8%Insiders
Ownership
Insiders1.84%957,247
Institutions125.99%65,664,624
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Anish BhatnagarCEOCHIEF EXECUTIVE OFFICER · Director
1.12%583,656
Mackaness James HCHIEF FINANCIAL OFFICER
0.25%131,763
Manning MeredithChief Commercial Officer
0.12%64,507
Huang Michael F.Sr. VP of Clinical Development
0.08%39,823
Fulk JenniferCHIEF FINANCIAL OFFICER
0.08%39,200
Yen KristenSEE REMARKS
0.07%37,639
Hirano Patricia CSEE REMARKS
0.04%22,702
Joshi ManherChief Development Officer
0.04%20,171
Norrett KevinChief Business Officer
0.03%17,786

Institutional holders 259

View all →
HolderValue% of shares
Fmr LLC$374.07M15.50%
Janus Henderson Group PLC$237.63M13.62%
BlackRock, Inc.$179.26M7.43%
Wellington Management Group LLP$153.85M6.38%
Vanguard Group Inc$141.69M5.87%
Avoro Capital Advisors LLC$134.27M5.56%
State Street Corporation$122.68M5.08%
Nantahala Capital Management, LLC$60.84M2.52%
Commodore Capital LP$55.56M2.30%
Braidwell LP$55.00M2.28%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 27, 2026Manning Meredith
Executive
SellCommon Stock$146.1K-5K
-6.75%
67,165
0.13% of shares
medium
Mar 27, 2026Huang Michael F.
Executive
SellCommon Stock$127.8K-4K
-9.17%
42,149
0.08% of shares
medium
Mar 27, 2026Manning Meredith
Executive
SellCommon Stock$65.2K-2K
-3.13%
65,065
0.12% of shares
low
Mar 27, 2026Huang Michael F.
Executive
SellCommon Stock$57.0K-2K
-4.36%
40,311
0.08% of shares
low
Mar 27, 2026Manning Meredith
Executive
SellCommon Stock$17.7K-558
-0.86%
64,507
0.12% of shares
low
Mar 27, 2026Huang Michael F.
Executive
SellCommon Stock$15.5K-488
-1.21%
39,823
0.08% of shares
low
Jan 21, 2026Norrett Kevin
Executive
GrantCommon Stock$0+4K
+24.50%
17,786
0.03% of shares
low
Jan 21, 2026Hirano Patricia C
Executive
GrantCommon Stock$0+10K
+84.54%
22,702
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Janus Henderson Group PLCPassive13G/A———
Wellington Management Group LLPPassive13G———
Avoro Capital Advisors LLCPassive13G———
Janus Henderson Group PLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SLNO——834203309—